Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
NeuroLing Oy
OY
Dissolved
Y-tunnus 3256398-3
Vetotie 3, 01610
Vantaa
Other human health activities n.e.c.
·
NACE 8699
Est. 2021 · 4 years old
— employees
Share
Finland
/
Companies
/
Other human health activities n.e.c.
/
NeuroLing Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
1M
1M
1M
0M
0M
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 1M
1M
2025
EBITDA
EUR millions
1M
1M
1M
0M
0M
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
Revenue
561
392
337
0
Staff expenses
−32
11
7
—
EBITDA
46
768
632
−14
Depreciation & amort.
—
—
—
—
EBIT
46
15
42
−14
Net financials
—
—
—
−1
Profit before tax
46
15
40
−16
Tax
−9
3
5
−0
Net profit
37
12
35
−16
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
Total assets
97
87
48
12
Equity
66
31
19
−16
Long-term debt
—
0
5
27
Short-term debt
31
56
24
1
Total debt
31
56
29
28
Financial ratios
5-year trend
EBITDA margin
8,3 %
This company
15,8 %
Market median
This company
Market median
47% below market
2022
2025
Equity ratio
67,8 %
This company
38,2 %
Market median
This company
Market median
77% above market
2022
2025
Return on equity
56,4 %
This company
18,4 %
Market median
This company
Market median
207% above market
2022
2025
Net profit margin
6,6 %
This company
8,1 %
Market median
This company
Market median
19% below market
2022
2025
Asset turnover
5,78×
This company
1,12×
Market median
This company
Market median
416% above market
2022
2025
Debt / equity
0,47×
This company
0,62×
Market median
This company
Market median
24% below market
2022
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-12-01 – 2022-12-31
View
PDF
More on NeuroLing Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network